Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 1,2 Dihydronaphthalene Derivatives. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106946817A enables transition-metal-free synthesis of 1,2-dihydronaphthalene derivatives. This method offers high atom economy and simplified supply chain for pharmaceutical intermediates.
Patent CN108129287B discloses a novel FeCl2-catalyzed radical cyclization of methylenecyclopropanes and aldehydes, offering a cost-effective route for high-purity pharmaceutical intermediates.